Kexing Biopharm Co., Ltd.
SHH: 688136.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yanqing Zhao
- Employees
- 1,407
- Headquarters
- Jinan, China
- IPO year
- 2020
- Market cap
- CN¥5.0B
- Website
- http://www.kexing.com
Loading 688136…
Loading profile data…Frequently asked questions about 688136
What does Kexing Biopharm Co., Ltd. (688136.SS) do?
Kexing Biopharm Co., Ltd. engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally. The company focuses on pharmaceutical research in the therapeutic fields of antiviral, tumor and immunity, blood, digestion, and degenerative diseases. Its products include...
Where does 688136.SS trade?
Kexing Biopharm Co., Ltd. (688136.SS) trades on the Shanghai Stock Exchange.
What sector is 688136.SS in?
Kexing Biopharm Co., Ltd. (688136.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kexing Biopharm Co., Ltd.?
Yanqing Zhao is the chief executive officer of Kexing Biopharm Co., Ltd. (688136.SS).
Where is Kexing Biopharm Co., Ltd. headquartered?
Kexing Biopharm Co., Ltd. is headquartered in China.
Does 688136.SS pay a dividend?
Yes — Kexing Biopharm Co., Ltd. (688136.SS) paid a trailing twelve-month dividend of CNY 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688136.SS go public?
Kexing Biopharm Co., Ltd. (688136.SS) completed its initial public offering in 2020.